Samjo Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$249K Buy
+5,200
New +$223K 0.09% 53
2026
Q1
Sell
-5,200
Closed -$265K 59
2025
Q4
$265K Sell
5,200
-100
-2% -$5.11K 0.1% 52
2025
Q3
$294K Hold
5,300
0.11% 54
2025
Q2
$366K Hold
5,300
0.15% 51
2025
Q1
$368K Sell
5,300
-100
-2% -$8.26K 0.16% 51
2024
Q4
$465K Hold
5,400
0.18% 46
2024
Q3
$643K Hold
5,400
0.22% 42
2024
Q2
$771K Hold
5,400
0.29% 39
2024
Q1
$693K Sell
5,400
-150
-3% -$17.9K 0.24% 37
2023
Q4
$574K Buy
+5,550
New +$549K 0.2% 35

Other funds holding NVO

Samjo Management's NVO Position: Q2 2026 in Review

Samjo Management opened a new position in Novo Nordisk (NVO) in Q2 2026: 5,200 shares worth $249K. The stake represents 0.09% of the portfolio and ranks #53 among its holdings. This is a return to the name: Samjo Management previously reported a position in NVO as recently as Q4 2025.

Samjo Management first reported a position in NVO in Q4 2023 and has held it in 10 quarters since. The position peaked at $771K in Q2 2024. 1,352 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Samjo Management held 5,200 shares of Novo Nordisk worth $249K as of Q2 2026.
  • Novo Nordisk was a new Samjo Management position in Q2 2026.
  • Novo Nordisk made up 0.09% of Samjo Management's portfolio in Q2 2026, its #53 holding.
  • Samjo Management first reported a position in Novo Nordisk in Q4 2023 and has held it in 10 quarters since.
  • Samjo Management's Novo Nordisk position peaked at $771K in Q2 2024.
  • 1,352 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Samjo Management's 13F filing for Q2 2026, filed 14 Aug 2026.